Literature DB >> 20452498

Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse.

Anna C Frick1, Mark D Walters, Kathleen S Larkin, Matthew D Barber.   

Abstract

OBJECTIVE: The aim of this study was to assess the risk of unanticipated abnormal gynecologic pathology at the time of reconstructive pelvic surgery to better understand risks of uterine conservation in the surgical treatment of uterovaginal prolapse. STUDY
DESIGN: This was a retrospective analysis of pathology findings at hysterectomy with reconstructive pelvic surgery over a 3.5-year period.
RESULTS: Seventeen of 644 patients had unanticipated premalignant or malignant uterine pathology (2.6%; 95% confidence interval, 1.7-4.2). Two (0.3%; 95% confidence interval, 0.09-1.1) had endometrial carcinoma. All cases of unanticipated disease were identified in postmenopausal women.
CONCLUSION: Premenopausal women with uterovaginal prolapse and normal bleeding patterns or with negative evaluation for abnormal uterine bleeding have a minimal risk of abnormal gynecologic pathology. In postmenopausal women without bleeding, the risk of unanticipated uterine pathology is 2.6% but may be reduced by preoperative endometrial evaluation. However, in women with a history of postmenopausal bleeding, even with a negative endometrial evaluation, we do not recommend uterine preservation at the time of prolapse surgery. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20452498     DOI: 10.1016/j.ajog.2010.01.077

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  26 in total

Review 1.  Management options for women with uterine prolapse interested in uterine preservation.

Authors:  Nathan Kow; Howard B Goldman; Beri Ridgeway
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

Review 2.  Uterine-preserving POP surgery.

Authors:  Robert Gutman; Christopher Maher
Journal:  Int Urogynecol J       Date:  2013-11       Impact factor: 2.894

3.  Perioperative complications following colpocleisis with and without concomitant vaginal hysterectomy.

Authors:  Katarzyna Bochenska; Alix Leader-Cramer; Margaret Mueller; Bhumy Davé; Alexandria Alverdy; Kimberly Kenton
Journal:  Int Urogynecol J       Date:  2017-05-03       Impact factor: 2.894

Review 4.  Sacrospinous hysteropexy: review and meta-analysis of outcomes.

Authors:  Shveta Kapoor; Kanapathippillai Sivanesan; Jessica Amy Robertson; Mayooran Veerasingham; Vishal Kapoor
Journal:  Int Urogynecol J       Date:  2017-03-03       Impact factor: 2.894

5.  Primary invasive carcinoma of the vagina after Le Fort partial colpocleisis for stage IV pelvic organ prolapse: a case report.

Authors:  Moon Kyoung Cho; Chul Hong Kim; Yoon Ha Kim
Journal:  Int Urogynecol J       Date:  2011-05-12       Impact factor: 2.894

Review 6.  The Manchester procedure versus vaginal hysterectomy in the treatment of uterine prolapse: a review.

Authors:  Cæcilie Krogsgaard Tolstrup; Gunnar Lose; Niels Klarskov
Journal:  Int Urogynecol J       Date:  2016-08-02       Impact factor: 2.894

7.  Hysterectomy at the time of colpocleisis: a decision analysis.

Authors:  Keisha A Jones; Yueran Zhuo; Senay Solak; Oz Harmanli
Journal:  Int Urogynecol J       Date:  2015-12-12       Impact factor: 2.894

8.  Utility of preoperative endometrial assessment in asymptomatic women undergoing hysterectomy for pelvic floor dysfunction.

Authors:  Olga Ramm; Jonathan L Gleason; Saya Segal; Danielle D Antosh; Kimberly S Kenton
Journal:  Int Urogynecol J       Date:  2012-03-08       Impact factor: 2.894

9.  Oestrogen-soaked vaginal packing for decubitus ulcer in advanced pelvic organ prolapse: a case series.

Authors:  Bahiyah Abdullah; Su Yen Khong; Peng Chiong Tan
Journal:  Int Urogynecol J       Date:  2015-12-30       Impact factor: 2.894

10.  Trends in use of surgical mesh for pelvic organ prolapse.

Authors:  Michele Jonsson Funk; Autumn L Edenfield; Virginia Pate; Anthony G Visco; Alison C Weidner; Jennifer M Wu
Journal:  Am J Obstet Gynecol       Date:  2012-11-15       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.